These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7585117)

  • 1. Multidrug resistance: locked in the vault?
    Rome LH
    Nat Med; 1995 Jun; 1(6):527. PubMed ID: 7585117
    [No Abstract]   [Full Text] [Related]  

  • 2. Transporter molecules in multidrug resistance.
    Scheper RJ; Scheffer GL; Flens MJ; van der Valk P; Broxterman HJ; Izquierdo MA
    Cytotechnology; 1996; 19(3):187-90. PubMed ID: 8862005
    [No Abstract]   [Full Text] [Related]  

  • 3. Relationship of LRP-human major vault protein to in vitro and clinical resistance to anticancer drugs.
    Izquierdo MA; Scheffer GL; Flens MJ; Shoemaker RH; Rome LH; Scheper RJ
    Cytotechnology; 1996; 19(3):191-7. PubMed ID: 8862006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The drug resistance-related protein LRP is the human major vault protein.
    Scheffer GL; Wijngaard PL; Flens MJ; Izquierdo MA; Slovak ML; Pinedo HM; Meijer CJ; Clevers HC; Scheper RJ
    Nat Med; 1995 Jun; 1(6):578-82. PubMed ID: 7585126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Major vault protein LRP-related multidrug resistance.
    Izquierdo MA; Scheffer GL; Flens MJ; Schroeijers AB; van der Valk P; Scheper RJ
    Eur J Cancer; 1996 Jun; 32A(6):979-84. PubMed ID: 8763338
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug retention, efflux, and resistance in tumor cells.
    Krishan A; Fitz CM; Andritsch I
    Cytometry; 1997 Dec; 29(4):279-85. PubMed ID: 9415409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The structure of cellular vaults, their role in the normal cell and in the multidrug resistance of cancer].
    Szaflarski W; Nowicki M; Zabel M
    Postepy Biochem; 2011; 57(3):266-73. PubMed ID: 22235652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical and clinical aspects of efflux pump related resistance to anti-cancer drugs.
    Aszalos A; Ross DD
    Anticancer Res; 1998; 18(4C):2937-44. PubMed ID: 9713488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Broad distribution of the multidrug resistance-related vault lung resistance protein in normal human tissues and tumors.
    Izquierdo MA; Scheffer GL; Flens MJ; Giaccone G; Broxterman HJ; Meijer CJ; van der Valk P; Scheper RJ
    Am J Pathol; 1996 Mar; 148(3):877-87. PubMed ID: 8774142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of major vault protein (MVP) in drug resistance.
    Park K
    J Control Release; 2012 Oct; 163(2):266. PubMed ID: 23083532
    [No Abstract]   [Full Text] [Related]  

  • 11. [Study on tumor cells' multidrug resistance and its reversion by Chinese herbs].
    Chen XY; Liu JT
    Zhong Xi Yi Jie He Xue Bao; 2003 Sep; 1(3):221-5. PubMed ID: 15339569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Up-regulation of vaults may be necessary but not sufficient for multidrug resistance.
    Siva AC; Raval-Fernandes S; Stephen AG; LaFemina MJ; Scheper RJ; Kickhoefer VA; Rome LH
    Int J Cancer; 2001 Apr; 92(2):195-202. PubMed ID: 11291045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Mr 193,000 vault protein is up-regulated in multidrug-resistant cancer cell lines.
    Schroeijers AB; Siva AC; Scheffer GL; de Jong MC; Bolick SC; Dukers DF; Slootstra JW; Meloen RH; Wiemer E; Kickhoefer VA; Rome LH; Scheper RJ
    Cancer Res; 2000 Feb; 60(4):1104-10. PubMed ID: 10706131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biology of the multidrug resistance-associated protein, MRP.
    Loe DW; Deeley RG; Cole SP
    Eur J Cancer; 1996 Jun; 32A(6):945-57. PubMed ID: 8763335
    [No Abstract]   [Full Text] [Related]  

  • 15. IL-2 gene transfer for chemosensitization of multidrug-resistant human colon carcinoma cells.
    Stein U; Walther W; Shoemaker RH; Schlag PM
    Adv Exp Med Biol; 1998; 451():145-9. PubMed ID: 10026864
    [No Abstract]   [Full Text] [Related]  

  • 16. Lung resistance-related protein: determining its role in multidrug resistance.
    Dalton WS; Scheper RJ
    J Natl Cancer Inst; 1999 Oct; 91(19):1604-5. PubMed ID: 10511581
    [No Abstract]   [Full Text] [Related]  

  • 17. Cellular functions of vaults and their involvement in multidrug resistance.
    Steiner E; Holzmann K; Elbling L; Micksche M; Berger W
    Curr Drug Targets; 2006 Aug; 7(8):923-34. PubMed ID: 16918321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence that vault ribonucleoprotein particles localize to the nuclear pore complex.
    Chugani DC; Rome LH; Kedersha NL
    J Cell Sci; 1993 Sep; 106 ( Pt 1)():23-9. PubMed ID: 8270627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression profiles of vault components MVP, TEP1 and vPARP and their correlation to other multidrug resistance proteins in ovarian cancer.
    Szaflarski W; Sujka-Kordowska P; Pula B; Jaszczyńska-Nowinka K; Andrzejewska M; Zawierucha P; Dziegiel P; Nowicki M; Ivanov P; Zabel M
    Int J Oncol; 2013 Aug; 43(2):513-20. PubMed ID: 23739867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Doxorubicin-resistant variants of human prostate cancer cell lines DU 145, PC-3, PPC-1, and TSU-PR1: characterization of biochemical determinants of antineoplastic drug sensitivity.
    David-Beabes GL; Overman MJ; Petrofski JA; Campbell PA; de Marzo AM; Nelson WG
    Int J Oncol; 2000 Dec; 17(6):1077-86. PubMed ID: 11078791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.